[HTML] nih.gov

[HTML][HTML] Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients

A Almufleh, J Marbach, S Chih, E Stadnick… - American journal of …, 2017 - ncbi.nlm.nih.gov
Background: Sacubitril/Valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The …
被引用次数：143 相关文章

Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients

A Almufleh, J Marbach, S Chih… - American journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Sacubitril/Valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The …
[PDF] academia.edu

[PDF][PDF] Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients

A Almufleh, J Marbach, S Chih, E Stadnick… - Am J Cardiovasc …, 2017 - academia.edu
Background: Sacubitril/Valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The …
[PDF] e-century.us

[PDF][PDF] Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients

A Almufleh, J Marbach, S Chih, E Stadnick… - Am J Cardiovasc …, 2017 - e-century.us
Background: Sacubitril/Valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The …

Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients.

A Almufleh, J Marbach, S Chih, E Stadnick… - American Journal of …, 2017 - europepmc.org
Background Sacubitril/Valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The …
[PDF] researchgate.net

[PDF][PDF] Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients

A Almufleh, J Marbach, S Chih, E Stadnick… - Am J Cardiovasc …, 2017 - researchgate.net
Background: Sacubitril/Valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The …
[PDF] researchgate.net

[PDF][PDF] Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients

A Almufleh, J Marbach, S Chih, E Stadnick… - Am J Cardiovasc …, 2017 - researchgate.net
Background: Sacubitril/Valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The …

Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients.

A Almufleh, J Marbach, S Chih, E Stadnick… - American Journal of …, 2017 - europepmc.org
Background Sacubitril/Valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The …